Clinical Trials
Phesi Powers Data-Driven Clinical Trials Through Addition of New Country Selection Functionality to ClinSite
Phesi, a data-driven provider of clinical development analytics products and solutions, announced a new country selection functionality has been added to ClinSite, its platform...
News
Toppan Subsidiary Okapi Pharmacy Launches Medicine Delivery Service
Okapi Pharmacy, a wholly-owned subsidiary of Toppan Printing, a global leader in communication, security, packaging, décor materials, and electronics solutions, has announced the launch...
Press Releases
Glenmark introduces higher strength (400 mg) of FabiFlu to reduce pill burden of COVID-19 treatment
Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, announced that it will introduce a 400 mg version of oral antiviral FabiFlu®, for the treatment...
Press Releases
Cherwell launches new support hub for growing Redipor prepared media distributor network
Cherwell Laboratories, specialist suppliers of environmental monitoring and process validation solutions for the pharmaceutical and related industries, has launched a Redipor® prepared media distributor...
News
YoSync Collaborates with IIIT Bangalore to Launch India’s First-Ever COVID-19 Blockchain Platform, BelYo
YoSync, a startup incubated at IIITB-IMACX Studios, signed a research collaboration in agreement with IIIT Bangalore, to partner with BelfricsBT, a Malaysian based blockchain...
News
Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced Phase 1 data from its Phase 1/2 randomized, observer-blinded, placebo-controlled...
Press Releases
Johnson & Johnson Announces Agreement with U.S. Government for 100 Million Doses of Investigational COVID-19 Vaccine
Johnson & Johnson announced its Janssen Pharmaceutical Companies have entered into an agreement with the U.S. government for the large scale domestic manufacturing and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
